期刊文献+

癫痫患者丙戊酸血药浓度监测及其影响因素 被引量:7

Determination of valproic acid serum concentrations and its influencing factors
原文传递
导出
摘要 目的:研究癫痫患者丙戊酸血药浓度的影响因素及血药浓度与疗效的关系。方法:采用气相色谱法对317例癫痫患者进行丙戊酸血药浓度监测,分析性别、年龄、体质量日剂量、剂型与(CSS/D)的关系以及合并用药对丙戊酸血药浓度的影响。结果:通过方差分析,性别组P>0.05;年龄、体质量日剂量组及不同剂型组P<0.05;合并卡马西平组的平均血药浓度比单服丙戊酸组的低;回归分析体质量日剂量是最主要影响因素。结论:性别对丙戊酸浓度无影响,年龄、体质量日剂量、剂型对丙戊酸浓度有重要意义,其中体质量日剂量的影响最显著,同时合并用药亦可影响丙戊酸的血药浓度。 OBJECTIVE To study the influencing factors of valproic acid (VPA)serum concentrauon in pauents wire epnepsy and the relalions between VPA serum concentration and clinic effect. METHODS Valproic acid serum concentration of epileptic (CSS)was monitored by gas chromatography, and to evaluate the influence of gender, age, standard dosage(D),dosage form on the specific value of serum concentration and standard dosagc(CSS/D), also the relation between combining use of drugs and serum concentration can be analyzed. RESULTS Variance analysis results showed thai gender had no siganificant differences(P〉0. 05) ; there were significant, difference in group of age, standard dosage and dosage form (P〈0. 05). The average serum concentrations of combining carbarnazepine was lower than the group taking VPA only; standard dosage was the main influencing factor by regression analysis. CONCLUSION Age, standard dosage, dosage form can effect valproic acid serum con- centrations, especially standard dosage but gender, and combining use of drugs also is an influencing factor.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2010年第15期1300-1302,共3页 Chinese Journal of Hospital Pharmacy
基金 湖南省科学技术厅科技计划资助项目(编号:2008sk3096)
关键词 丙戊酸 血药浓度 方差分析 体质量日剂量 valproic acid serum concentrations variance analysis
  • 相关文献

参考文献3

二级参考文献8

共引文献14

同被引文献51

  • 1刘治军,李可欣,刘志鹤,杨莉萍,孙春华.1 882人4 092次治疗药物监测数据统计及结果分析[J].中国医院药学杂志,2006,26(1):96-97. 被引量:6
  • 2任榕娜,黄铃沂,陈新民,叶礼燕,黄俊景.儿童癫癎丙戊酸用药个体化治疗观察[J].中国实用儿科杂志,2006,21(5):393-393. 被引量:12
  • 3孙妍萍,谭兰,宋敬卉.CYP2A6基因多态性对丙戊酸钠血药浓度的影响[J].中华神经科杂志,2006,39(11):745-747. 被引量:15
  • 4陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:3465.
  • 5国家药典委员会.药物制剂人体生物利用度和生物等效性研究技术指导原则[M]//中华人民共和国药典:二部.北京:中国医药科技出版社,2010:附录ⅪⅩB195.
  • 6贾建平.神经病学[M].7版.北京:人民卫生出版社,2013:235-237.
  • 7GALLAGHER R M, BIRD K A, MASON J R, el al. Adverse drug reactions causing admission to a paediatric hospital: a pilot study [J].J Clin Pharm Ther,2011,36(2) :194-199.
  • 8Johannessen SI. Can pharmacokinetic variability be con- trolled for the patient' s benefit? The place of TDM for new AEDs[ J]. Ther Drug Monit, 2005,27(6) : 710.
  • 9Zhou JQ, Zhou LM, Chen L J, et al. Polycystic ovary sy- ndrome in patients with epilepsy: a study in 102 Chinese women[J]. Seizure, 2012,21 (9) : 729.
  • 10Meischenguiser R, D' Giano CH, Ferraro SM. Oxcarbaz- epine in pregnancy: clinical experience in Argentina[J].EpilepsyBehav, 2004,5(2):163.

引证文献7

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部